Houston, TX, May 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s peripheral arterial disease (“PAD”) product, Atherectomy Catheter II, is a catheter-based platform capable of treating a broad range of plaque types, including calcified plaque and addresses many […]
Other News
Eko Launches First AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exams, Providing Clinicians with In-Person Level Exam Capabilities During Video Visits
Used by more than 200 health systems for telehealth, platform goes beyond standard video conferencing to facilitate stethoscope audio, ECG live-streaming and FDA-cleared identification of atrial fibrillation (AFib) and heart murmurs Patients can video chat with their providers and navigate self-operated stethoscope exams OAKLAND, Calif.–(BUSINESS WIRE)–Eko today announced Eko Telehealth, the first […]
VSMS ECG Patch receives US FDA ‘Emergency Use Authorisation’ for patients being treated for COVID-19
Patch now authorised in the USA for emergency use for patients undergoing treatment for COVID-19 Patch entitled for reimbursement under US CPT code scheme – adds to GMV’s growing revenue profile Large addressable market for G Medical – ~1.5m confirmed cases of COVID-19 recorded in the US[i] so far Fast route to market […]
HeartHero Partners With Sudden Cardiac Arrest Survivor
The story and voice inside HeartHero’s Elliot DENVER–(BUSINESS WIRE)–HeartHero’s industry disruptive Automated External Defibrillator (AED), Elliot, has found its voice in Sudden Cardiac Arrest Survivor Carrie “Zapgirl” Romero. Drawn to HeartHero’s name and mission, Romero, a professional Voice Actor, long-time AED Advocate, and ICD patient, reached out to HeartHero’s CEO […]
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
WARRINGTON, Pa., May 20, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced the pricing of its public offering of 2,758,620 units at a price to the public of $7.25 per […]
Ra Medical Systems Announces Pricing of $10.0 Million Public Offering
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 22,222,222 shares of common […]
Thermedical’s Groundbreaking SERF Ablation System Earns FDA’s Breakthrough Device Designation
WALTHAM, Mass.–(BUSINESS WIRE)–Thermedical®, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate® catheter. The FDA Breakthrough Devices Program is intended to help patients […]
Cathvision Completes New Investment Round of a Total 13M Euro
COPENHAGEN, May 19, 2020 /PRNewswire/ — CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed an investment round of a total 13M euro. Both existing and new investors participated in the round. The proceeds allow the company to begin multi-center clinical studies and complete […]
Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy
VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications GOTHENBURG, Sweden, May 19, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), today announced the global introduction of its seventh-generation simulation platform – VIST® G7 to become the endovascular simulation platform for Mentice solutions including […]
Novoheart Holdings Inc. Reports First Quarter 2020 Financial Results and Announces AGM Results
VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three months ended March 31, 2020. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS). “Since the outbreak of […]



